Cargando…
Response to “Reassessing the death risk related to probiotics in critically ill patients”
Autores principales: | Manzanares, William, Wischmeyer, Paul E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330025/ https://www.ncbi.nlm.nih.gov/pubmed/28241845 http://dx.doi.org/10.1186/s13054-017-1618-0 |
Ejemplares similares
-
Reassessing the death risk related to probiotics in critically ill patients
por: Maraolo, Alberto Enrico
Publicado: (2016) -
Erratum to: Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis
por: Manzanares, William, et al.
Publicado: (2017) -
Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis
por: Manzanares, William, et al.
Publicado: (2016) -
Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illness
por: Wischmeyer, Paul E., et al.
Publicado: (2016) -
Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19
por: Whittle, John, et al.
Publicado: (2020)